Skip to main content
The first in a new class of orexin receptor antagonists has been approved by the FDA for the treatment of insomnia. Orexins are hypothalamic neuropeptides that appear to have a role in maintaining wakefulness.

Pharmacology Update - Suvorexant Tablets (Belsomra ®)